Inventor · disambiguated record
Joseph R. Garlich
Also filed as: GARLICH JOSEPH R
33 granted patents·7 pending applications·1,476 citations·filing 1988–2021
98Inventor score
Files withDOW CHEMICAL CO22SIGNALRX PHARMACEUTICALS INC9SEMAFORE PHARMACEUTICALS INC7GARLICH JOSEPH R1MORALES GUILLERMO A1
Top patents by PatentIndex Score
40 records- 0197US5342604AComplexes possessing ortho ligating functionalityDOW CHEMICAL CO·Filed 1992·Granted Aug 30, 1994·97 cites·8 claims
- 0296US5714631AConjugates possessing ortho ligating functionalityDOW CHEMICAL CO·Filed 1996·Granted Feb 3, 1998·78 cites·4 claims
- 0396US5696239AConjugates possessing ortho ligating functionality and complexes thereofDOW CHEMICAL CO·Filed 1995·Granted Dec 9, 1997·82 cites·43 claims
- 0495US5750660ABicyclopolyazamacrocyclophosphonic acid half estersDOW CHEMICAL CO·Filed 1996·Granted May 12, 1998·82 cites·11 claims
- 0595US5435990AMacrocyclic congugates and their use as diagnostic and therapeutic agentsDOW CHEMICAL CO·Filed 1992·Granted Jul 25, 1995·140 cites·40 claims
- 0694US5059412AMacrocyclic aminophosphonic acid complexes for the treatment of calcific tumorsDOW CHEMICAL CO·Filed 1988·Granted Oct 22, 1991·52 cites·88 claims
- 0793US9505780B2Thienopyranones as kinase and epigenetic inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·9 cites·2 claims
- 0891US10308662B2Thienopyranones as kinase and epigenetic inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2017·Granted Jun 4, 2019·6 cites·11 claims
- 0991US6949537B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2004·Granted Sep 27, 2005·63 cites·20 claims
- 1091US5756065AMacrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agentsDOW CHEMICAL CO·Filed 1995·Granted May 26, 1998·130 cites·26 claims
- 1191US5286479AOral compositions for suppressing mouth odorsDOW CHEMICAL CO·Filed 1991·Granted Feb 15, 1994·125 cites·31 claims
- 1291US4882142ABone marrow suppressing agentsDOW CHEMICAL CO·Filed 1988·Granted Nov 21, 1989·58 cites·30 claims
- 1389US9981983B2Thienopyranones as kinase inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·5 cites·4 claims
- 1489US9550790B2Thienopyranones as kinase inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·8 cites·1 claims
- 1589US4937333AMethod for purifying aminomethylenephosphonic acids for pharmaceutical useDOW CHEMICAL CO·Filed 1989·Granted Jun 26, 1990·31 cites·16 claims
- 1688US10174032B2Heterocyclic compound classes for signaling modulationSIGNALRX PHARMACEUTICALS INC·Filed 2015·Granted Jan 8, 2019·6 cites·2 claims
- 1788US5652361AMacrocyclic ligands and complexesDOW CHEMICAL CO·Filed 1993·Granted Jul 29, 1997·109 cites·81 claims
- 1887US5739294ABicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agentsDOW CHEMICAL CO·Filed 1994·Granted Apr 14, 1998·84 cites·24 claims
- 1984US7662977B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2007·Granted Feb 16, 2010·8 cites·21 claims
- 2083US5133956ARadiolabeled metal-binding protein for the treatment of arthritisDOW CHEMICAL CO·Filed 1991·Granted Jul 28, 1992·49 cites·16 claims
- 2181US8557807B2Thienopyranones as kinase inhibitorsMORALES GUILLERMO A·Filed 2009·Granted Oct 15, 2013·13 cites·6 claims
- 2281US7396828B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2005·Granted Jul 8, 2008·5 cites·2 claims
- 2379US11472814B2Thienopyranones and furanopyranones as checkpoint inhibitors and modulators of anti-tumor immunitySIGNALRX PHARMACEUTICALS INC·Filed 2018·Granted Oct 18, 2022·3 cites·18 claims
- 2474US5064633AMacrocyclic aminophosphonic acid complexes, their formulations and useDOW CHEMICAL CO·Filed 1989·Granted Nov 12, 1991·44 cites·36 claims
- 2574US4976950ABone marrow suppressing agentsDOW CHEMICAL CO·Filed 1989·Granted Dec 11, 1990·43 cites·21 claims
- 2667US5300279AOrganic amine phosphonic acid complexes for the treatment of calcific tumorsDOW CHEMICAL CO·Filed 1990·Granted Apr 5, 1994·32 cites·42 claims
- 2767US2009011975A1Targeted bone marrow protection agentsSEMAFORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2866US5300289APhytate antimicrobial compositions in oral care productsDOW CHEMICAL CO·Filed 1991·Granted Apr 5, 1994·33 cites·32 claims
- 2964US5308606AMethod of treating and/or diagnosing soft tissue tumorsDOW CHEMICAL CO·Filed 1991·Granted May 3, 1994·28 cites·14 claims
- 3061US5762907AFrozen radiopharmaceutical formulationsDOW CHEMICAL CO·Filed 1993·Granted Jun 9, 1998·25 cites·38 claims
- 3159US2008292714A1Bone targeting of degradable drug filled nanoparticlesSEMAFORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3258US5320829AOral compositions for inhibiting plaque formationDOW CHEMICAL CO·Filed 1991·Granted Jun 14, 1994·21 cites·8 claims
- 3358US2017101418A1Thienopyranones as Kinase and Epigenetic InhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3457US11760762B2Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2018·Granted Sep 19, 2023·0 cites·6 claims
- 3554US2023165873A1Methods of Use for Single Molecule Compounds Providing Multi-Target Inhibition to Treat Covid 19SIGNALRX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3653US2007104645A1Chelate based scaffolds in tumor targetingGARLICH JOSEPH R·Filed 2004·Application pending·0 cites
- 3748US2004198783A1Targeted bone marrow protection agentsSEMAFORE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3845US2007203098A1Pten InhibitorsSEMAFORE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3937US5318772AOral compositions for inhibiting calculus formationDOW CHEMICAL CO·Filed 1991·Granted Jun 7, 1994·5 cites·6 claims
- 4032US5342925ARadioactive compositions for soft tissue tumorsDOW CHEMICAL CO·Filed 1991·Granted Aug 30, 1994·2 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Joseph R. Garlich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →